AP NEWS
Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

Chronic Disease Management: Therapeutics, Device Technologies and Global Markets, 2018-2019 & 2024 - ResearchAndMarkets.com

December 3, 2019

DUBLIN--(BUSINESS WIRE)--Dec 3, 2019--

The “Chronic Disease Management: Therapeutics, Device Technologies and Global Markets” report has been added to ResearchAndMarkets.com’s offering.

This report is an analytical business tool with the primary purpose of providing a thorough evaluation of the global market for chronic disease management through various therapeutics and advanced device technologies.

Report Scope

Market Insights

This market growth is fueled by a growing geriatric population, changing lifestyle, increasing prevalence of chronic diseases, superior clinical results of new drugs and biologics, increasing trend of digital health, the U.S.

Patient Protection and Affordable Care Act, increasing awareness in the developed world, strong research and development (R&D) initiatives from key market players, increasing government initiatives, patient assistance programs, regulatory efforts to provide smooth regulatory approval process, adoption of portable/wearable device technologies and adoption of advanced software applications; further, key drivers for the market include smart pills, targeted therapy, advanced needle-free drug delivery technologies, drug-device combinations and development of home-care and self-medication devices.

However, some of the key market barriers are lack of awareness in underdeveloped countries, poor medication adherence, patent expiry blockbuster drugs and biologics, shorter product life cycles for device technologies, regulatory issues (stringent regulatory approval procedure), increasing R&D cost, health disparities in low-income countries, higher cost of the cancer treatment, data privacy, data security and data accuracy.

Regionally, the U.S. is expected to maintain dominance in the therapeutics and device technologies segments of global chronic disease management market. Those wishing to invest in the chronic disease management therapeutics and device technologies market ought to strongly consider high-growth areas such as pharmaceutical drugs, biologics, medical device technologies and software applications.

Key Topics Covered

Chapter 1 Introduction

Chapter 2 Summary and Highlights

Chapter 3 Chronic Diseases and Growing Burden on Economy

Chapter 4 Chronic Diseases: Therapeutics

Chapter 5 Device Technologies and Applications

Chapter 6 Chronic Diseases: Treatment Adherence Devices and Applications

Chapter 7 Market Size and Growth Analysis

Chapter 8 Competitive Landscape in the Chronic Disease Management Market

Chapter 9 Strategies in the Chronic Disease Management Market

Chapter 10 Regulatory Structure: Pharmaceuticals and Medical Devices

Chapter 11 Pricing and Reimbursement: Pharmaceuticals and Medical Devices

Chapter 12 Conclusions - Outlook for Chronic Disease Management

Chapter 13 Company Profiles

Chapter 14 Appendix A: List of Acronyms

Chapter 15 Appendix B: Professional Organizations

For more information about this report visit https://www.researchandmarkets.com/r/hgb4oe

View source version on businesswire.com:https://www.businesswire.com/news/home/20191203005779/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

KEYWORD:

INDUSTRY KEYWORD: MANAGED CARE PHARMACEUTICAL HEALTH MEDICAL DEVICES

SOURCE: Research and Markets

Copyright Business Wire 2019.

PUB: 12/03/2019 11:07 AM/DISC: 12/03/2019 11:07 AM

http://www.businesswire.com/news/home/20191203005779/en